Related Experiment Video
Updated: May 8, 2026

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
Programmed cell death-4 deficiency prevents diet-induced obesity, adipose tissue inflammation, and insulin resistance
Qun Wang1, Zhaojing Dong, Xianglan Liu
1Department of Immunology, Shandong University School of Medicine, Jinan, Shangdong, China.
Abstract:
Programmed cell death-4 (PDCD4), a selective protein translation inhibitor, has shown proinflammatory effect in some inflammatory diseases, but its roles in obesity remain unestablished. This study aims to investigate the effects of PDCD4 on obesity, inflammation, and insulin resistance. Surprisingly, high-fat diet (HFD)-fed PDCD4-deficient (PDCD4(-/-)) mice exhibited an absolutely lean phenotype together with improved insulin sensitivity. Compared with wild-type obese mice, HFD-fed PDCD4(-/-) mice showed higher energy expenditure, lower epididymal fat weight, and reduced macrophage infiltration inflammatory cytokine secretion in white adipose tissue (WAT). Alleviated hepatic steatosis along with decreased plasma levels of triglyceride and cholesterol was also observed in these mice. Importantly, PDCD4 appeared to disturb lipid metabolism via inhibiting the expression of liver X receptor (LXR)-α, a master modulator of lipid homeostasis, which was elevated in HFD-fed PDCD4(-/-) mice accompanied by upregulation of its target genes and relieved endoplasmic reticulum stress in WAT. These data demonstrate that PDCD4 deficiency protects mice against diet-induced obesity, WAT inflammation, and insulin resistance through restoring the expression of LXR-α, thereby proposing PDCD4 as a potential target for treating obesity-associated diseases.
Insights
Programmed cell death-4 (PDCD4) deficiency surprisingly protected mice from obesity and insulin resistance. PDCD4 inhibition improved energy expenditure and reduced inflammation, suggesting PDCD4 as a potential therapeutic target for metabolic diseases.
Area of Science:
- Metabolic disease research
- Cellular and molecular biology
- Inflammation and immunology
Background:
- Programmed cell death-4 (PDCD4) is a protein translation inhibitor with known proinflammatory effects.
- The specific role of PDCD4 in the development of obesity and associated metabolic dysfunction remains largely uncharacterized.
Purpose of the Study:
- To investigate the impact of PDCD4 on diet-induced obesity, inflammation, and insulin resistance.
- To elucidate the molecular mechanisms underlying PDCD4's influence on metabolic homeostasis.
Main Methods:
- Utilized high-fat diet (HFD)-fed wild-type and PDCD4-deficient (PDCD4(-/-)) mice.
- Assessed phenotypic changes including body weight, fat mass, energy expenditure, and insulin sensitivity.
- Analyzed white adipose tissue (WAT) for macrophage infiltration, inflammatory cytokine levels, and endoplasmic reticulum stress.
- Investigated the expression of liver X receptor-alpha (LXR-α) and its downstream targets.
Main Results:
- PDCD4(-/-) mice exhibited a lean phenotype and improved insulin sensitivity on an HFD.
- These mice displayed increased energy expenditure, reduced WAT inflammation, and alleviated hepatic steatosis.
- PDCD4 deficiency led to elevated LXR-α expression and its target genes, improving lipid metabolism and reducing ER stress in WAT.
Conclusions:
- PDCD4 deficiency confers protection against diet-induced obesity, adipose tissue inflammation, and insulin resistance.
- This protective effect is mediated by the restoration of LXR-α expression and improved lipid homeostasis.
- PDCD4 emerges as a promising therapeutic target for managing obesity and related metabolic disorders.
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Dipeptidyl Peptidase 4 Inhibitors
The Extrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
Type I Diabetes II: Pathophysiology
Abnormal Proliferation

